Short interest in Stoke Therapeutics Inc (NASDAQ:STOK) decreased during the last reporting period, falling from 6.79M to 6.70M. This put 18.89% of the company's publicly available shares short.

Short interest for Stoke Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Stoke Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 300.06K shares traded per day, it would take 22.33 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.